Healthcare Costs of Treating Privately Insured Patients with Acute Myeloid Leukemia in the United States 2004–2014: A Generalized Additive Modeling Approach

OBJECTIVES: To predict healthcare cost trajectories for patients with newly diagnosed acute myeloid leukemia (AML) receiving allogeneic hematopoietic cell transplantation (alloHCT), as a function of days since chemotherapy initiation, days relative to alloHCT and days before death or last date of in...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Pharmacoeconomics
Autori principali: Mau, Lih-Wen, Preussler, Jaime M., Burns, Linda J., Leppke, Susan, Majhail, Navneet S., Meyer, Christa L., Mupfudze, Tatenda, Saber, Wael, Steinert, Patricia, Vanness, David J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7194165/
https://ncbi.nlm.nih.gov/pubmed/32128725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40273-020-00891-w
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi